Krystal Biotech, Inc. (KRYS) Tops Q4 EPS by 1c

Krystal Biotech, Inc. (NASDAQ: KRYS) reported Q4 EPS of ($1.25), $0.01 better than the analyst estimate of ($1.26).

For earnings history and earnings-related data on Krystal Biotech, Inc. (KRYS) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Deere shares climb as fiscal Q3 earnings and revenue top estimates
• Rubrik Inc (RBRK) PT Raised to $120 at Cantor Fitzgerald Into Q2 Earnings